ORIC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. ORIC has a great financial health rating, but its profitability evaluates not so good. ORIC has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year ORIC has reported negative net income.
In the past year ORIC has reported a negative cash flow from operations.
ORIC had negative earnings in each of the past 5 years.
In the past 5 years ORIC always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -31.37%, ORIC is in the better half of the industry, outperforming 66.48% of the companies in the same industry.
Looking at the Return On Equity, with a value of -33.24%, ORIC is in the better half of the industry, outperforming 74.10% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-31.37%
ROE	-33.24%
ROIC	N/A

ROA(3y)-40.88%

ROA(5y)-34.73%

ROE(3y)-45.86%

ROE(5y)-38.37%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ORIC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, ORIC has more shares outstanding
The number of shares outstanding for ORIC has been increased compared to 5 years ago.
There is no outstanding debt for ORIC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 23.92 indicates that ORIC is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 23.92, ORIC belongs to the top of the industry, outperforming 91.24% of the companies in the same industry.
ORIC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	23.92

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

ORIC has a Current Ratio of 14.65. This indicates that ORIC is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 14.65, ORIC belongs to the best of the industry, outperforming 91.24% of the companies in the same industry.
A Quick Ratio of 14.65 indicates that ORIC has no problem at all paying its short term obligations.
ORIC has a better Quick ratio (14.65) than 91.24% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	14.65
Quick Ratio	14.65

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.89% over the past year.

EPS 1Y (TTM)3.89%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%32.65%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, ORIC will show a small growth in Earnings Per Share. The EPS will grow by 3.13% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y12.68%

EPS Next 2Y5.7%

EPS Next 3Y1.61%

EPS Next 5Y3.13%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ORIC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ORIC. No positive earnings are expected for the next year.